The Regulatory Affairs 2024 conference is a dynamic forum that brings together experts, professionals, and stakeholders from the pharmaceutical industry. This hybrid event aims to explore the latest trends, challenges, and innovations in regulatory affairs within the Nordics and Baltics.
Participants will engage in insightful sessions covering topics such as current trends in EU pharmaceutical legislation and the digital future (AI, ePIL, paperless PIL, multi-language labelling). The event also includes panel discussion on drug shortages on the Baltics and Nordics.
Join us at Regulatory Affairs 2024 to gain valuable insights, exchange knowledge, and contribute to shaping the future of Regulatory Affairs!
Target group
Professionals with an interest in Regulatory Affairs in Nordic and Baltic countries. We welcome participants from pharmaceutical companies, pharmaceutical industry associations, national competent authorities, consultants and academia.
Why participate?
- Stay Informed: Get up-to-date insights on the latest trends and developments in EU pharmaceutical legislation.
- Get the latest update about ePIL from different perspectives.
- Explore AI in Regulatory Affairs: How artificial intelligence cloud be shaping regulatory affairs.
- Panel Discussion on Shortages: Engage in a discussion about drug shortages on the area. Contribute to finding solutions and best practices.
- Network with Industry Experts: Connect with professionals, authorities, and stakeholders from the pharmaceutical industry. Exchange knowledge, build relationships, and expand your network..
Program
The program is created together with industry experts from the Nordic and Baltic countries.
Check the content and speakers from the Program tab!
Planning Group
Audrone Jurkeviciute, Novartis
Birgit Jensen, Link Medical
Camilla Skogman-Lindqvist, Novartis
Hele Anderspunk , Pfizer
Henrik Fant, Gedeon Richter
Jan Thomasen, Cencora Pharmalex
Karlis Andersons, Merck
Ulla Partanen, Pharmaca Health Intelligence
Price and registration
You can participate in the hybrid event either on-site or remotely, in a live webinar. In both modes of participation, you will see and hear the trainers, you can join the discussion in real time via chat and download the lecture materials for yourself. On site, you will get to network with colleagues and we will offer you a breakfast, lunch and afternoon coffee. We will send a personal welcome message to all participants before the event. The price includes the webinar recording, which is available to you for one month after the live event.
Take advantage of the Early Bird offer and register for 495 € before 9.4.2024. After that, the normal price is 595 €. All prices excl. VAT. VAT 24% is applied to participants from Finland.
Group discounts
- 20% discount for groups of 3 or more participants: Use discount code 4YOU20. Group discount is calculated from normal price.
- 25% discount for groups of 5 or more participants: Use discount code 4YOU25. Group discount is calculated from normal price.
- Larger group or unlimited organization access: Please request an offer here.
Please read the change and cancellation terms before registering under: Instructions for participants. Pharmaca reserves the right to make changes to the event.
Please note that the original event date was 6.6.2024. The event date was changed on February.
Feedback from previous events
- ”The diversity of topics! It was interesting to get different aspects of the regulatory work in the Nordics/EU”
- ”Speakers were true experts of the area they were presenting. Really interesting presentations.”
- ”Interesting, contemporary topics, good speakers, good facilitator”
- ”The presence of all Nordic authorities in one place. Very interesting also to hear about the work of EFPIA to get the high level as well.”
In this training, you have new registration features at your disposal: card payment and group registration. When using the promotional code, please check that the final price is correct. The processing of invoices is faster, since the invoices are created automatically based on the information you provide, so please add the PO number when registering. Please primarily use the form's company search.
